IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes

IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes

Copyright © 2015 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 162(2016) vom: 01. Jan., Seite 45-8
Auteur principal: Dereke, Jonatan (Auteur)
Autres auteurs: Nilsson, Charlotta, Strevens, Helena, Landin-Olsson, Mona, Hillman, Magnus
Format: Article en ligne
Langue:English
Publié: 2016
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't Gestational diabetes mellitus Glutamic acid decarboxylase antibodies IgG subclasses Type 1 diabetes C-Peptide Immunoglobulin G Glutamate Decarboxylase EC 4.1.1.15
Accès en ligne Volltext